R & D SYSTEMS search R & D Systems MMP9 products
includes other brands or spellings
|
| elisa | | R & D Systems human recombinant MMP-9 and MMP-9 (4H3, mIgG1) antibody was used in ELISA to study the migratory-adhesive switch in Ewing's Sarcoma Cells triggered by matrix metalloproteinase-9 silencing. |
| ih | | R&D Systems monoclonal mouse anti-MMP-9 antibody was used in immunohistochemistry to study the expression of neutrophil gelatinase–associated lipocalin in atherosclerosis and myocardial infarction. |
SIGMA-ALDRICH search Sigma-Aldrich MMP9 products
includes other brands or spellings
|
| elisa | | Sigma Chemical mouse monoclonal anti-human MMP-9 antibody was used in ELISA to study the effects of interleukin (IL) -10 on MMP-2 expression in CPTX-1532 human prostate tumor cells. |
| ih | | Sigma MMP9 antibody was tested in immunohistochemistry by Human Protein Atlas. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology MMP9 products
includes other brands or spellings
|
| ic | | Santa Cruz Biotechnology goat polyclonal anti-human MMP-9 antibody was used in human choriocarcinoma cell line JEG-3 and in immunocytochemistry to study the role of interleukin (IL) 12 in regulating trophoblast invasion and the expression of trophoblast proteases using an in vitro tissue culture system of human choriocarcinoma cell line JEG-3. |
| ih, ip, wb | | Santa Cruz Biotechnology goat anti-MMP-9 polyclonal antibody was used in western blot, immunoprecipitation and immunohistochemistry to study the expression of neutrophil gelatinase–associated lipocalin in atherosclerosis and myocardial infarction. |
| ih, wb | | Santa Cruz Biotechnology rabbit polyclonal anti-MMP-9 antibody was used in human MCF-7 cells and paraffin sections from human tumor, and which were respectively in western blot and immunohistochemistry, to study the role for the effect of hypoxia on cross-talk between Syk and Lck in breast cancer progression and angiogenesis. |
| wb | | Santa Cruz Biotechnology MMP-9 rabbit polyclonal antibody was used in western blot to study the inhibition of matrix metalloproteinase-9 expression by ascochlorin. |
EMD BIOSCIENCES search EMD Biosciences MMP9 products
includes other brands or spellings
|
| block | | Oncogene monoclonal anti-MMP-9 antibody (Ab-3) was used in blocking expriments to identify an integrin-binding motif in progelatinases. |
| ih, wb | | Oncogene Research Products antibody to MMP-9 was used in western blot to analyze MMP-9 levels in extracts of preterm human fetal membranes, and in immunohistochemistry to detect MMP-9 expression in term human fetal membrane and different types of placental cells including sycytiotrophoblast cells, chorionic trophoblast cells, amnion epithelial cells and amnion mesenchymal cells. |
| ih | | CalBiochem anti-MMP-9 antibody was used in immunohistochemistry to study the its upregulation in human invasive glioma. |
| wb | | Oncogene Research Products anti-MMP-9 antibody was used in western blot to study the associativity of expression of thrombospondin-1 and osteopontin with absence or presence metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. |
MILLIPORE search Millipore MMP9 products
includes other brands or spellings
|
| ih | | Chemicon mouse monoclonal antibody which recognizes both the pro- and active forms of human MMP-9 (MAB3309; clone 56-2A4) was used in immunohistochemistry to detect MMP-9 expression in human carcinoma and stromal cells. |
| wb | | Chemicon Polyclonal anti-MMP-9 antibody was used in western blot to study that disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. |
| wb | | Chemicon MMP-9 antibody against N-terminal region of the active form was used in western blot to study airway smooth muscle function modulation. |
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific MMP9 products
includes other brands or spellings
|
| block | | Lab Vision monoclonal anti-MMP-9 antibody (GE-213) was used in blocking expriments to identify an integrin-binding motif in progelatinases. |
| ih | | Lab Vision/NeoMarkers MMP9 antibody was tested in immunohistochemistry by HPA (HPA001238) . |
| ih | | NeoMarkers monoclonal antibody for MMP-9 was used in immunohistochemistry to detect MMP-9 in the human cervix. |
| ih | | NeoMarkers monoclonal MMP-9 (GE-213) antibody was used in immunohistochemistry to study the expression of MMP-9 and TIMP-1 in gastric carcinoma. |
GE HEALTHCARE LIFE BIOSCIENCES search GE Healthcare Life Biosciences MMP9 products
includes other brands or spellings
|
| elisa | | Amersham Bioscience MMP-9 ELISA kit was used to study up-regulation of matrix metalloproteases by TNF alpha. |
| elisa | | Amersham Pharmacia Biotech anti-MMP-9 antibody was used in ELISA to study the increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary. |
BIODESIGN
|
| elisa | | Biodesign sheep anti-MMP-9 antibody was used in ELISA to study the ability of Fusobacterium nucleatum subsp. nucleatum to increase its tissue-invasive potential by acquiring cell-associated human matrix metalloproteinase 9 (MMP-9) activity. |
DAIICHI FINE CHEMICAL CO LTD
|
| ih | | Daiichi Fine Chemical Co. Ltd. antihuman MMP-9 monoclonal antibody (mouse IgG1/kappa, F-69) was used in immunohistochemistry to detect MMP-9 expression in human non–small-cell lung cancer (NSCLC) and stromal fibroblasts. |
DAIICHI FINE CHEMICALS
|
| ih | | Daiichi Fine Chemicals mouse monoclonal anti-human MMP-9 antibody was used in immunohistochemisty to study the association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. |
FUJI CHEMICAL INDUSTRIES
|
| ih | | Fuji Chemical Industries monoclonal anti-MMP-9 antibody (56-2A4) was used in paraffin sections from human tumor and in immunohistochemistry to study the value of the RECK and MMP-9 as prognostic indicator for colorectal cancer. |
Articles Reviewed |
| 1. Virginia Urquidi et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. 2002 |
| 2. Ping Xu et al. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. 2002 |
| 3. Denis Stygar et al. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. 2002 |
| 4. Sheng Zhang et al. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. 2003 |
| 5. Michael Stefanidakis et al. Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins. 2003 |
| 6. Josiane Sancéau et al. Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. 2003 |
| 7. Min Zhou et al. Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. 2003 |
| 8. Tomomitsu Okamoto et al. Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary. 2003 |
| 9. Thorsten Hagemann et al. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. 2004 |
| 10. Sung-Kwon Moon et al. Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. 2004 |
| 11. Mark E Stearns et al. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells. 2004 |
| 12. Taku Takeuchi et al. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. 2004 |
| 13. Hiroyuki Yamamoto et al. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. 2004 |
| 14. Renée Gendron et al. Binding of pro-matrix metalloproteinase 9 by Fusobacterium nucleatum subsp. nucleatum as a mechanism to promote the invasion of a reconstituted basement membrane. 2004 |
| 15. Subhradip Karmakar et al. Inhibition of cytotrophoblastic (JEG-3) cell invasion by interleukin 12 involves an interferon gamma-mediated pathway. 2004 |
| 16. Shinya Ishikawa et al. Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer. 2004 |
| 17. Johanna M Pellikainen et al. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. 2004 |
| 18. Ping Guo et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. 2005 |
| 19. SaHyun Hong et al. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. 2005 |
| 20. Anne-Louise Hemdahl et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. 2006 |
| 21. Goutam Chakraborty et al. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis. 2006 |
| 22. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |